Cargando…

Bufalin induces DNA damage response under hypoxic condition in myeloma cells

Hypoxia serves a crucial role in the development of drug resistance in various cancer cells. Therefore, many attempts targeting hypoxia are underway to overcome the drug resistance mediated by hypoxia. This strategy is useful for multiple myeloma (MM) cells, as MM cells reside within the bone marrow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Eri, Inada, Yuki, Kakoki, Misaki, Nishimura, Nao, Endo, Shinya, Fujiwara, Shiho, Wada, Naoko, Kawano, Yawara, Okuno, Yutaka, Sugimoto, Toshiya, Hata, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876453/ https://www.ncbi.nlm.nih.gov/pubmed/29616114 http://dx.doi.org/10.3892/ol.2018.8091

Ejemplares similares

Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1
por: Fujiwara, Shiho, et al.
Publicado: (2015)

Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
por: KAWANO, YAWARA, et al.
Publicado: (2013)

Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
por: KAWANO, YAWARA, et al.
Publicado: (2012)

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
por: WADA, NAOKO, et al.
Publicado: (2014)

Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib‐sensitive and ‐resistant multiple myeloma cells
por: Nishimura, Nao, et al.
Publicado: (2019)

Enhanced Intestinal Permeability of Bufalin by a Novel Bufalin-Peptide-Dendrimer Inclusion through Caco-2 Cell Monolayer
por: Chan, Chi-on, et al.
Publicado: (2017)

Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
por: Wen, Lili, et al.
Publicado: (2014)

Synthesis and Biological Evaluation of Novel Bufalin Derivatives
por: Sampath, VishnuPriya, et al.
Publicado: (2022)

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022)

PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013)

Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis
por: LingHu, Hai Rui, et al.
Publicado: (2020)

Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis
por: Fujimoto, Yuki, et al.
Publicado: (2021)

Base-to-apex gradient pattern of cardiac impairment identified on myocardial T1 mapping in cardiac amyloidosis
por: Oda, Seitaro, et al.
Publicado: (2018)

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017)

The Mechanism of Bufalin-Induced Apoptosis of K562/A02
por: Xie, Ying, et al.
Publicado: (2019)

A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice
por: Liu, Miao, et al.
Publicado: (2016)

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
por: Xiang, Ru-Fang, et al.
Publicado: (2017)

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
por: Zhang, Zhou-Ji, et al.
Publicado: (2014)

Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins
por: Wang, Haiyong, et al.
Publicado: (2018)

Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis
por: Kang, Kyung-Hwa, et al.
Publicado: (2017)

Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer
por: Yuan, Ze-Ting, et al.
Publicado: (2017)

Bufalin suppresses ovarian cancer cell proliferation via EGFR pathway
por: Dou, Lei, et al.
Publicado: (2022)

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023)

Targeting Poly (ADP-Ribose) Polymerase Partially Contributes to Bufalin-Induced Cell Death in Multiple Myeloma Cells
por: Huang, He, et al.
Publicado: (2013)

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Qiu, Dong-Ze, et al.
Publicado: (2013)

Radiosynthesis and pharmacokinetics of [(18)F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
por: Yang, Zhaoshuo, et al.
Publicado: (2017)

Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
por: Yuan, Jiani, et al.
Publicado: (2019)

Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
por: Sun, Jian, et al.
Publicado: (2017)

Effect of Bufalin-PLGA Microspheres in the Alleviation of Neuropathic Pain via the CCI Model
por: Long, Lina, et al.
Publicado: (2022)

Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cells in vitro: Association with the Induction of Apoptosis in Leukemia HL‐60 Cells
por: Jing, Yongkui, et al.
Publicado: (1994)

Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221
por: Zhang, Jianjun, et al.
Publicado: (2016)

Bufalin induced apoptosis of bladder carcinoma cells through the inactivation of Na+K+-ATPase
por: Huang, Houbao, et al.
Publicado: (2018)

Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS
por: Han, Mengfei, et al.
Publicado: (2020)

Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide
por: Liu, Jia, et al.
Publicado: (2019)

Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice
por: Zhang, Jinghui, et al.
Publicado: (2021)

Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021)

Therapeutic Targets of Bufalin on Renal Carcinoma and Mechanisms: Experimental Validation of Network Pharmacology Analysis
por: Zhang, Lei, et al.
Publicado: (2022)

Bufalin suppresses colorectal cancer cell growth through promoting autophagy in vivo and in vitro
por: Pan, Zhe, et al.
Publicado: (2018)

Myristoyl group-aided protein import into the mitochondrial intermembrane space
por: Ueda, Eri, et al.
Publicado: (2019)

Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer
por: Hu, Qiang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_514dg2jgfimgsf2l0r1kf8r0e6